Equity Details
Price & Market Data
Price: $0.462
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $42,567,524
Daily Volume: 0
Performance Metrics
1 Week: 10.11%
1 Month: -1.60%
3 Months: 0.16%
6 Months: -6.50%
1 Year: -4.31%
YTD: -4.07%
About NUREXONE BIOLOGIC INC (NRXBF)
Dive into the latest financial snapshot of NUREXONE BIOLOGIC INC (NRXBF). With a current trading price of 0.462, the stock has experienced a daily shift of $0.00 / 0.00%. The company's market capitalization stands impressively at 42,567,524. Track its year-to-date performance, which is at -4.07%, alongside its weekly, monthly, and yearly trends.
Details
NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It develops and commercializes the ExoTherapy platform for production of exosome-loaded nanodrugs. The company is also developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis caused by spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat traumatic brain injuries and other neurological conditions. Its technology includes ExoPTEN for the treatment of acute spinal cord injury and glaucoma; and Exosomes as a drug delivery system for regeneration and healing of specific tissues. The company was founded in 2020 and is based in Toronto, Canada.